Physician profile
Jacquelyn D Macintosh
NPI 1346696531
$7,322.87
in general payments reported to CMS, 2019-2025
36 companies · $502 in 2025
The $502 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $4,170 · 2021: $833 · 2022: $740 · 2023: $370 · 2024: $370 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,059.55 | 2020-2023 | Da Vinci Surgical System |
| Abbvie INC. | $1,000.57 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $254.03 | 2022-2025 | |
| Astellas Pharma US INC | $183.29 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $179.56 | 2021-2025 | Slynd |
| Pfizer INC. | $133.23 | 2021-2025 | |
| Therapeuticsmd, INC. | $122.08 | 2019-2021 | |
| Organon LLC | $111.62 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $101.01 | 2020 | |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Sumitomo Pharma America, INC. | $95.94 | 2024-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $92.29 | 2021-2024 | |
| Aspira Women'S Health INC | $88.62 | 2022 | |
| Hologic Sales and Service, LLC | $79.62 | 2024-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Amgen INC. | $77.83 | 2020-2025 | Evenity, Prolia, Prolia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $69.38 | 2023 | Balcoltra |
| Agile Therapeutics, INC. | $62.45 | 2021-2024 | Twirla |
| Millicent US INC | $62.27 | 2023-2025 | Femlyv, Femring, Intrarosa |
| Dexcom, INC. | $50.59 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $49.38 | 2022-2025 | |
| Exact Sciences Corporation | $47.05 | 2024-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $44.70 | 2021-2022 | |
| Daiichi Sankyo INC. | $39.11 | 2022 | |
| Novo Nordisk INC | $32.84 | 2022-2024 | Wegovy |
| Ethicon US, LLC | $27.96 | 2022 | |
| Roche Diagnostics Corporation | $16.91 | 2021 | |
| Evofem Biosciences, INC. | $15.94 | 2021 | |
| Axonics, INC. | $15.81 | 2024 | Bulkamid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.46 | 2020 | |
| Minerva Surgical, INC | $14.28 | 2025 | |
| Scynexis, INC. | $14.25 | 2022 | |
| Currax Pharmaceuticals LLC | $14.13 | 2024 | Onzetra Xsail, Contrave |
| Lupin INC. | $14.11 | 2019 | |
| Eisai INC. | $13.53 | 2021 | |
| Mylan Pharmaceuticals INC. | $12.83 | 2021 | |
| Vivus LLC | $11.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Macintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.